Visualization of chronic myocardial infarction using the intravascular contrast agent MS-325 (gadofosveset) in patients

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Thouet, Thomas ^a   Schnackenburg, Bernhard ^b   Kokocinski, Thomas ^a   Fleck, Eckart ^a   Nagel, Eike ^c   Kelle, Sebastian ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b PHILIPS HEALTHCARE   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOFOSVESET; PENTETIC ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM; GADOLINIUM PENTETATE; ORGANOMETALLIC COMPOUND;

ACCURACY; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HEART INFARCTION; HUMAN; MAGNETIC RESONANCE CORONARY ARTERY IMAGING; MALE; MULTICENTER STUDY; MYOCARDIAL PERFUSION IMAGING; PHASE 2 CLINICAL TRIAL; SENSITIVITY AND SPECIFICITY; STANDARD; CLINICAL TRIAL; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED;

ADULT; AGED; CHRONIC DISEASE; CONTRAST MEDIA; FEMALE; GADOLINIUM; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS;

EID: 84859715412     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/236401     Document Type: Article

References (29)

1. Parmelee D. J., Walovitch R. C., Ouellet H. S., Lauffer R. B., Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging Investigative Radiology 1997 32 12 741 747 (Pubitemid 28053505)
2. Lauffer R. B., Parmelee D. J., Ouellet H. S., Dolan R. P., Sajiki H., Scott D. M., Bernard P. J., Buchanan E. M., Ong K. Y., Tyeklr Z., Midelfort K. S., McMurry T. J., Walovitch R. C., MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging Academic Radiology 1996 3 supplement 2 S356 S358
3. Lauffer R. B., Parmelee D. J., Dunham S. U., Ouellet H. S., Dolan R. P., Witte S., McMurry T. J., Walovitch R. C., MS-325: albumin-targeted contrast agent for MR angiography Radiology 1998 207 2 529 538 (Pubitemid 28259074)
4. Grist T. M., Korosec F. R., Peters D. C., Witte S., Walovitch R. C., Dolan R. P., Bridson W. E., Yucel E. K., Mistretta C. A., Steady-state and dynamic MR angiography with MS-325: initial experience in humans Radiology 1998 207 2 539 544 (Pubitemid 28259075)
5. Bluemke D. A., Stillman A. E., Bis K. G., Grist T. M., Baum R. A., D'Agostino R., Malden E. S., Pierro J. A., Yucel E. K., Carotid MR angiography: phase II study of safety and efficacy for MS-3251 Radiology 2001 219 1 114 122 (Pubitemid 32234062)
6. Hofman M. B., Adzamli K., Allen J. S., Fischer S. E., Brown J. J., Adams M. D., Wickline S. A., Lorenz C. H., Kinetics of a novel blood pool agent (MP-2269) with persistent high relaxivity for MR angiography Academic Radiology 1998 5 supplement 1 S206 S209
7. Kelle S., Thouet T., Tangcharoen T., Nassenstein K., Chiribiri A., Paetsch I., Schnackenburg B., Barkhausen J., Fleck E., Nagel E., Whole-heart coronary magnetic resonance angiography with MS-325 (Gadofosveset) Medical Science Monitor 2007 13 11 CR469 CR474
8. Klein C., Schalla S., Schnackenburg B., Bornstedt A., Hoffmann V., Fleck E., Nagel E., Improvement of image quality of non-invasive coronary artery imaging with magnetic resonance by the use of the intravascular contrast agent Clariscan (NC100150 injection) in patients with coronary artery disease Journal of Magnetic Resonance Imaging 2003 17 6 656 662 (Pubitemid 36665869)
9. Schwitter J., Saeed M., Wendland M. F., Derugin N., Canet E., Brasch R. C., Higgins C. B., Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents Journal of the American College of Cardiology 1997 30 4 1086 1094 (Pubitemid 27435906)
10. Flacke S., Allen J. S., Chia J. M., Wible J. H., Periasamy M. P., Adams M. D., Adzamli I. K., Lorenz C. H., Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model Radiology 2003 226 3 731 738 (Pubitemid 36259149)
11. Dewey M., Kaufels N., Laule M., Schnorr J., Raynaud J. S., Hamm B., Taupitz M., Magnetic resonance imaging of myocardial perfusion and viability using a blood pool contrast agent Investigative Radiology 2004 39 8 498 505 (Pubitemid 38982153)
12. Kelle S., Roes S. D., Klein C., Kokocinski T., de Roos A., Fleck E., Bax J. J., Nagel E., Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging Journal of the American College of Cardiology 2009 54 19 1770 1777
13. Roes S. D., Kelle S., Kaandorp T. A. M., Kokocinski T., Poldermans D., Lamb H. J., Boersma E., van der Wall E. E., Fleck E., de Roos A., Nagel E., Bax J. J., Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction American Journal of Cardiology 2007 100 6 930 936 (Pubitemid 47368098)
14. Wellnhofer E., Olariu A., Klein C., Grfe M., Wahl A., Fleck E., Nagel E., Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery Circulation 2004 109 18 2172 2174 (Pubitemid 38625392)
15. Gibbons R. J., Valeti U. S., Araoz P. A., Jaffe A. S., The quantification of infarct size Journal of the American College of Cardiology 2004 44 8 1533 1542 (Pubitemid 39377707)
16. Kim R. J., Fieno D. S., Parrish T. B., Harris K., Chen E. L., Simonetti O., Bundy J., Finn J. P., Klocke F. J., Judd R. M., Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 1999 100 19 1992 2002 (Pubitemid 29529292)
17. Kim R. J., Wu E., Rafael A., Chen E. L., Parker M. A., Simonetti O., Klocke F. J., Bonow R. O., Judd R. M., The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction New England Journal of Medicine 2000 343 20 1445 1453
18. Thiele H., Kappl M. J. E., Conradi S., Niebauer J., Hambrecht R., Schuler G., Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging Journal of the American College of Cardiology 2006 47 8 1641 1645
19. Caravan P., Cloutier N. J., Greenfield M. T., McDermid S. A., Dunham S. U., Bulte J. W. M., Amedio J. C., Looby R. J., Supkowski R. M., Horrocks W. D., McMurry T. J., Lauffer R. B., The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates Journal of the American Chemical Society 2002 124 12 3152 3162 (Pubitemid 34249987)
20. Look D. C., Locker D. R., Time saving in measurement of NMR and EPR relaxation times Review of Scientific Instruments 1970 41 2 250 251
21. Baierl P., Seiderer M., Heywang S., Rath M., The contrast to noise ratio as a measure of tissue contrast in nuclear magnetic resonance tomography Digitale Bilddiagnostik 1986 6 3 101 110
22. Kroft L. J. M., Doornbos J., van der Geest R. J., de Roos A., Blood pool contrast agent CMD-A2-Gd-DOTA-enhanced MR imaging of infarcted myocardium in pigs Journal of Magnetic Resonance Imaging 1999 10 2 170 177 (Pubitemid 29362432)
23. Grebe O., Paetsch I., Kestler H. A., Herkommer B., Schnackenburg B., Hombach V., Fleck E., Nagel E., Optimal acquisition parameters for contrast enhanced magnetic resonance imaging after chronic myocardial infarction Journal of Cardiovascular Magnetic Resonance 2003 5 4 575 587 (Pubitemid 37420772)
24. Flacke S. J., Fischer S. E., Lorenz C. H., Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction Radiology 2001 218 3 703 710 (Pubitemid 32172551)
25. Oshinski J. N., Yang Z., Jones J. R., Mata J. F., French B. A., Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging Circulation 2001 104 23 2838 2842 (Pubitemid 33126660)
26. Saeed M., Weber O., Lee R., Do L., Martin A., Saloner D., Ursell P., Robert P., Corot C., Higgins C. B., Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media Journal of the American College of Cardiology 2006 48 10 1961 1968 (Pubitemid 44738439)
27. Gaillard S., Kubiak C., Stolz C., Bonnemain B., Chassard D., Safety and pharmacokinetics of P792, a new blood-pool agent: results of clinical testing in nonpatient volunteers Investigative Radiology 2002 37 4 161 166 (Pubitemid 34259725)
28. Port M., Corot C., Violas X., Robert P., Raynal I., Gagneur G., How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity Investigative Radiology 2005 40 9 565 573 (Pubitemid 41208633)
29. Kroft L. J. M., de Roos A., Blood pool contrast agents for cardiovascular MR imaging Journal of Magnetic Resonance Imaging 1999 10 3 395 403 (Pubitemid 29463124)